Merck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production started quickly.

Merck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production started quickly.

Following in the footsteps of Gilead Sciences, Merck & Co. | Following in the footsteps of Gilead, Merck has signed voluntary licensing agreements to enable access to its…